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Abstract
Background: Oxidative stress enhances lipid peroxidation (LPO), which both are implicated in the promotion and
progression stages of carcinogenesis, in particular under conditions of chronic inflammation and infections.
Exocyclic etheno-DNA adducts, which are formed by LPO-products such as 4-hydroxy –2-nonenal, are strongly pro-
mutagenic DNA lesions.
Methods: The development of ultra-sensitive detection methods for etheno-adducts in human tissues, white
blood cells( WBC) and urine has provided evidence that these adducts are elevated in affected organs of cancer-
prone patients, probably acting as a driving force to malignancy.
Results: Two recent studies that yielded some new insights into disease causation are briefly reviewed:DNA-
damage in WBC of mother-newborn child pairs, and lipid peroxidation derived DNA damage in patients with
cancer-prone liver diseases. Our results indicate that biomonitoring of etheno-DNA adducts in humans are
promising tools (i) to better understand disease aetiopathogenesis, allowing hazard identification(ii) to monitor
disease progression and (iii) to verify the efficacy of chemopreventive and therapeutic interventions .Such clinical
trials are warranted.
Background
Oxidative stress enhances lipid peroxidation (LPO),
which both are implicated in the promotion and pro-
gression of chronic degenerative diseases (CDD) ,
including carcinogenesis, in particular under conditions
of chronic inflammation [1]. Common pathways of CDD
involve biologically reactive oxygen and nitrogen species
which can be generated by biochemical redox reactions
and stress response enzymes such as lipoxygenases,
cyclooxygenenase -2 and inducible nitric oxide synthase
[2]. The resulting oxidative stress is currently implicated
in over 100 human and animal CDD.Exocyclic etheno-
DNA adducts, which are formed by LPO- products such
as 4-hydroxy-2-nonenal (HNE), are strongly miscoding,
causing specific point mutations. The development of
ultra-sensitive detection methods for etheno-adducts in
human tissues, WBC and urine provided evidence that
these adducts are elevated in affected organs of cancer-
prone patients, suggesting that such DNA damage can
drive cells to malignancy [3].
A summary of studies that we have conducted is
depicted in Fig. 1; detailed adduct levels and results ( pub-
lished until 2007 ) are reviewed in reference [1]. Sources
of DNA damage that significantly increased the physiolo-
gical background of exocyclic etheno-DNA adducts were
found to be known human cancer risk factors such as i)
viral infections and chronic inflammatory processes, ii)
genetic cancer predisposing diseases, iii) nutritional factors
and iv) certain occupational exposures. The recent study
in a Danish cohort of mother- newborn child pairs is sepa-
rately dealt with.
In the following, recent studies in humans that yielded
some new insights into disease causation are briefly
reviewed: 1) DNA -damage in WBC DNA of mother-
newborn child pairs [4], and 2) Lipid peroxidation-
derived DNA damage in patients with cancer-prone
liver diseases [5]. Our results indicate that biomonitor-
ing of etheno-DNA adducts in humans are promising
tools (i) to better understand disease aetiopathogenesis,
allowing hazard identification, especially when combined
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patients with metal storage diseases), (ii) to monitor
diagnostic disease progression and (iii) to verify the effi-
cacy of chemopreventive and therapeutic interventions.
Such clinical trials are warranted and feasible due to the
available non-invasive biomarkers we have developed.
Methods
We have developed ultrasensitive, specific and artifact-
free detection methods using immunoenrichment that
allow the biomonitoring of etheno DNA adducts in
humans in vivo[1]. Protocols and technical details are
described in [6]. The high sensitivity and specificity of
the three methods (below) are due to the use of mono-
clonal antibodies. They recognize etheno-DNA adducts
specifically, allowing a) their immunopurification and
quantitation in human tissues, cells and in urine where
the adducts are excreted ; and b) their semiquantative
immunohistochemical detection in tissue mircoarrays.
-Adducts can now be quantified in tissue- and WBC-
DNA by an ultrasensitive immunoaffinity-
32P -postlabel-
ing method.
-Etheno-adducts excreted in urine can be measured by
an immuno-enrichment-HPLC-fluorescence method.
-Immunohistochemical staining in tissue sections
allows to assess the prevalence of etheno-adducts in the
nuclei of various cells and tissue types.
Results
Typical signature of exocyclic DNA damage measured
in a cohort of mother-newborn child pairs
DNA damage is commonly thought to be involved in
CDD causation, and its impact is particularly detrimen-
tal during fetal development. Hereby it is assumed that
oxidative stress-related damage targets stem cells and
their progenitors during differentiation, and that these
early induced DNA lesions could cause hematopoietic
disorders later in life. Within a multicenter study, we
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Figure 1 Studies that have demonstrated an increase in etheno-DNA adduct levels due to carcinogen exposure, acquired or inherited cancer
risk factors. DNA – damage occurs as a consequence of oxidative stress and LPO as shown in humans and rodent models (reviewed in [1,2] ).
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pairs to see if imprinting of DNA damage in mother
child shows a similar pattern; it is known that cord
blood is highly enriched with stem cells. Two etheno
DNA-adducts, εdA and εdC, were measured and their
levels (expressed per 10
9 parent nucleotides) in leuco-
cytes varied from 400-9000, demonstrating that even the
lowest levels could be reliably quantified by our detec-
tion method. In child cord blood adduct levels were
found to be about two times lower than in maternal
blood ,the difference being highly significant. Analysis of
εdA and εdC levels in cord versus maternal blood WBC
showed strong positive correlations (R
2 =0 . 9 ,P
<0.00001). Our results confirm that the DNA damage
observed in leucocytes, arises from LPO-derived reactive
a l d e h y d e ss u c ha sH N E ,a n ds u g g e s t st h a tat y p i c a ls i g -
nature of DNA damage is induced similarly in fetus and
mother [4]. Prospective cohort studies have to reveal
whether these exocyclic WBC-DNA adducts could serve
as predictive hazard indicator for developing hemato-
poietic cancers and other disorders later in life. Atten-
tion should be focused on outliers with extremely high
adduct levels that were also found in this study. Ana-
lyses by the study consortium whether specific expo-
sures measured in these populations are related to
etheno-adduct formation are in progress.
Lipid peroxidation-derived DNA adducts: potential early
hazard markers in patients with liver cancer -prone
diseases
Chronic alcohol abuse and hepatitis B, and C virus
(HBV, HCV) infection are causally associated with
increased risk of developing hepatocellular carcinoma
(HCC) which progresses through chronic hepatitis,
fibrosis and cirrhosis. The disease progression is asso-
ciated with intense oxidative stress in the liver, resulting
in an overproduction of reactive oxygen /nitrogen spe-
cies and LPO-products [7].
Our aims of the study were to ascertain whether (i)
etheno-adducts are formed in the liver of HCC-prone
patients, (ii) etheno-adducts (εdA) areexcreted in urine
and (iii) these adducts could serve as DNA damage (and
putative risk) marker during viral -and alcohol -related
liver cancer progression.
Studies in ALD patients
We analyzed εdA levels in DNA of needle liver biopsies
obtained from European ALD patients diagnosed with
alcohol-related hepatitis, fibrosis and cirrhosis using
immunohistochemistry [8]. Cell nuclei positively stained
for εdA were counted and the % prevalence was moni-
tored. When compared to asymptomatic livers, the
mean prevalence values were 16 times higher in biopsies
from fibrosis/cirrhosis patients. This increase was com-
parable to that found in liver of patients with primary
hemochromatosis, a genetically inherited disease highly
predisposing to HCC. In European ALD patients, we
a l s of o u n di nu r i n ea1 0f o l di n c r e a s e dεdA -level as
compared to healthy controls [9]. Thus high urinary
εdA -excretion mirrors the massive DNA damage gener-
ated in the liver of ALD patients.
Excessive etheno-DNA adducts found in ALD patients
are thought to be formed by the reaction of the major
LPO product 4-hydroxy-2-nonenal (HNE) with nucleo-
bases [5]. Confirmation for such a pathway in human
liver in vivo was for the first time obtained by showing
that protein- bound HNE and etheno adducts in ALD
liver biopsies were strongly intercorrelated . In addition
both markers correlated with CYP2E1 expression
(R
2=0.9, P =0.01)
Our data support that ethanol-mediated induction of
hepatic CYP2E1, leading to miscoding LPO-derived
DNA lesions plays a central role in hepatocarcinogen-
esis, particularly in Caucasian ALD patients.
Pilot studies in virus-infected patients
As found in ALD patients, also subjects with inflamma-
tory cancer -prone liver diseases caused by viral infec-
tion excreted high levels of εdA in urine [9]. Thai
patients with chronic hepatitis, liver cirrhosis and HCC
due to HBV-infection had 20, 73 and 39 times higher
urinary εdA-levels, respectively when compared with
asymptomatic HBsAg-carriers. In over two thirds of
European patients with HBV and HCV -related liver dis-
ease, urinary εdA levels were increased 6 to 10 fold [9].
From these studies we conclude that (i) high urinary
εdA-levels reflecting massive LPO-derived DNA-damage
in vivo may contribute to the development HCC; (ii) εdA-
measurments in urine and needle biopsies from target
tissues in affected patients should be explored as a putative
risk markers to follow malignant progression of inflamma-
tory liver diseases and (iii) etheno adducts in urine may
s e r v ea sn o n -i n v a s i v em a r k e rs to assess to efficacy of
chemopreventive and therapeutic interventions.
Discussion
Since more than two decades, starting under the director-
ship of Lorenzo Tomatis (from1982-1993) at IARC in
Lyon we pursued the following hypothesis: Major risk fac-
tors for various epithelial human cancers are endogenously
produced DNA reactive species , that arise from dietary
imbalance, chronic inflammation, persistent infections and
aberrant metal storage. These damaging agents escaped
detection by conventional biomonitoring and epidemiolo-
gical techniques. Therefore new approaches in molecular
epidemiology are required that include non- invasive
methods for identification of such DNA damage in
humans. We contributed to this paradigm by studying
modified DNA base adducts that are generated by reac-
tions of DNA with LPO-products, such as HNE that yield
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detection methods.
We then investigated pathological conditions and known
cancer risk factors that could significantly increase the phy-
siological background of etheno-adduct levels. A summary
of our previous studies is depicted in Fig. 1 . Our recent
mother- newborn child study is not ncluded as we are
unable to associate specific exposures/ life style factors with
etheno adduct formation in these WBC. In this biomonitor-
ing study we detected highly variable, and possibly cancer-
relevant DNA damage in WBC-DNA of mother-newborn
child pairs, conceivably derived from dietary imbalance and
life style factors. One source of etheno adduct may be
explained by our previous findings that high dietary omega-
6 polyunsaturated fatty acid (linoleic acid) intake drastically
increased the formation of etheno-DNA adducts in white
blood cells of female but not of male subjects [10]. In our
mother –child study the DNA damage observed in mater-
nal WBC-DNA was found to be very similar in DNA of
newborns. In addition (epi)genome - environment interac-
tions need to be further studied, so to allow better disease
risk evaluations and predictions in children.
Our other investigations in cancer prone patients
found progressively increasing DNA damage in preneo-
plastic liver tissue, due to alcohol abuse and viral infec-
tions, both causing chronic inflammation cascades that
impose persistent oxidative stress in this organ.As pub-
lished recently, tobacco smoking and UV- light induced
many thousands of sequence alterations and specific sig-
natures of somatic mutations in human lung cancer and
melanoma [11,12]. Exocyclic LPO- derived DNA-lesions
are likely to contribute to the mutation load reported to
occur in human tumors.
Outlook: Since the discontinuation of our research
project at DKFZ, there are a number of issues in rela-
tion to the utility of etheno adducts as biomarkers for
hazard identification that need to be resolved:
Only three studiesin humans( Fig.1) have shown a
positive relationship between etheno adduct formation
and exposure to specific agents: Linoleic acid(omega-6
PUFA), sodium chloride and alcohol.
In contrast to rodent studies, only a few dose-reponse
curves but mostly high vs low dose (intake) comparisons
were done. Etheno adducts in urine of Japanese subjects
living in a high risk area for gastric cancer were
positively associated with the excretion sodium chloride
( a risk factor for gastric cancer) and omega-6 polyunsa-
turated fatty acid intake .
The time window was mostly investigated in rodent
cancer models. In cancer prone-patients etheno adduct
levels progressively increased in target organs , being
highest in preneoplastic lesions with subsequent decline
i nt h et u m o rt i s s u e ,t h es a m et i m ec o u r s ea sa l s os e e n
in rodents.
The diagnostic and prognostic value of etheno adducts
,measured in needle tissue biopsies, white blood cells
and as urinary excretion products needs to be estab-
lished. Initial attempts to develop an inexpensive and
simple kit for adduct analysis to allow easy application
in clinical and epidemiologial studies, was not success-
ful. Ultrasensitive, specific mass- spectrometric methods
that have become available, should augur progress in
this validation process , allowing high throughput work
flow for large cohort analyses.
Conclusions
From consistent results obtained in our past conducted
studies ( Fig.1) we conclude:
(i) Etheno- adducts,stable DNA damage markers are
elevated by various cancer risk factors that impose oxi-
dative/ nitrosative stress and LPO on a cell.
(ii) Etheno-adducts progressively increased in many
target organs and preneoplastic lesions of cancer prone-
patients and rodents.
(iii) LPO-derived DNA adducts appear to be one of
the causes of mutations and genomic instability that
drives carcinogenesis, offering promising markers for
quantifying increasing loads of promutagenic DNA
damage in early stages of carcinogensis.
(iv) Etheno adducts in should be useful for etiology
studies on cancers with ill-defined mechanisms, such as
childhood malignancies: High DNA damage was found
in some newborn child -mother pairs for which the
cause is unknown.
From our findings in liver cancer prone patients we
conclude:
(i) High urinary εdA -levels reflecting massive LPO-
derived DNA damage in the affected liver, may contri-
bute to the initiation and progression of HCC.
(ii) Measurements of etheno adducts in urine and in
needle liver biopsies should be explored as a putative
risk markers to follow the malignant disease progression
in high risk patients patients and due to ALD and the
viral infections.
(iii) Etheno adducts as biomarkers hold promise to
assess the efficacy of chemopreventive and therapeutic
interventions and such clinical/biomonitoring trials are
warranted.
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